Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

Taylor N, Grabmeier-Pfistershammer K, Egle A, Greil R, Rieger A, Ledergerber B, Oberkofler H.

http://www.ncbi.nlm.nih.gov/pubmed/24023696